Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms and Therapeutic Targets of Ischemia-Reperfusion Injury in Stroke: A Narrative Review Focusing on Blood-Brain Barrier Dysfunction.

Brain sciences·2026
Same author

Characterizing the Treatment Courses of Ranibizumab and Panretinal Photocoagulation for Retinopathy of Prematurity.

Journal of pediatric ophthalmology and strabismus·2026
Same author

Targeting the c-Met/VEGFR Pathway to Boost <i>Nab</i>-Paclitaxel Efficacy in Gastric Cancer: Preclinical Insights.

Cells·2026
Same author

Expanding Horizons in Cholangiocarcinoma: Emerging Targets Beyond FGFR2 and IDH1.

International journal of molecular sciences·2025
Same author

Deciphering the neural signatures of auditory hallucinations in early-onset schizophrenia: A topological brain network analysis.

Schizophrenia research·2025
Same author

A Comparative Analysis and Phylogenetic Relationship of the Chloroplast Genome Sequences of <i>Illicium verum</i> and <i>Illicium difengpi</i>.

Genes·2025

Related Experiment Video

Updated: Jun 24, 2026

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
04:59

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Published on: July 7, 2023

Posterior capsular opacification: a problem reduced but not yet eradicated.

Niranjan Awasthi1, Suqin Guo, B J Wagner

  • 1Department of Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, USA. niranjan.awasthi@utsouthwestern.edu

Archives of Ophthalmology (Chicago, Ill. : 1960)
|April 15, 2009
PubMed
Summary

Posterior capsular opacification (PCO) remains a common complication after cataract surgery. This review explores PCO development mechanisms and strategies for its prevention and treatment.

More Related Videos

Modeling Cataract Surgery in Mice
05:19

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Related Experiment Videos

Last Updated: Jun 24, 2026

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries
04:59

Rotating the Intraocular Lens to Prevent Posterior Capsular Opacification in Cataract Surgeries

Published on: July 7, 2023

Modeling Cataract Surgery in Mice
05:19

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Area of Science:

  • Ophthalmology
  • Biomedical Engineering

Background:

  • Posterior capsular opacification (PCO) is the most common complication following cataract surgery.
  • While advancements have reduced PCO rates, it remains a significant clinical issue.
  • Current treatments like Nd:YAG laser capsulotomy have associated risks and costs.

Purpose of the Study:

  • To review the current understanding of PCO development mechanisms.
  • To discuss recent advances in surgical techniques, intraocular lens (IOL) technology, and therapeutic agents for PCO management.

Main Methods:

  • Literature review of studies on PCO pathogenesis and treatment.
  • Analysis of factors influencing PCO, including cellular processes and molecular mediators.
  • Evaluation of innovations in surgical procedures, IOL materials, and drug development.

Main Results:

  • PCO results from remnant lens epithelial cell proliferation, migration, epithelial-mesenchymal transition, collagen deposition, and lens fiber generation.
  • Cytokines, growth factors, and extracellular matrix proteins play crucial roles in PCO.
  • Progress in surgical techniques, IOL design, and therapeutic agents offers improved PCO eradication strategies.

Conclusions:

  • Understanding PCO mechanisms is key to developing effective interventions.
  • Continued innovation in surgical and material science, alongside targeted therapies, promises safer and more cost-effective PCO management.
  • Future strategies aim to prevent or eliminate PCO, improving patient outcomes after cataract surgery.